Article

Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral…

Behavioural Neurology · 2023 · Mahdieh Anoush, author Soroush Bijani, author Fatemeh Moslemifar, author Fatemeh Jahanpour, author Ali Kalantari-Hesari, author Mir-Jamal Hosseini, author Muh-Shi Lin, Academic Editor

Key facts

Title Edaravone Improves Streptozotocin-Induced Memory Impairment via Alleviation of Behavioral Dysfunction, Oxidative Stress, Inflammation, and Histopathological Parameters
First author Mahdieh Anoush, author Soroush Bijani, author Fatemeh Moslemifar, author Fatemeh Jahanpour, author Ali Kalantari-Hesari, author Mir-Jamal Hosseini, author Muh-Shi Lin, Academic Editor
Journal Behavioural Neurology
Published Mar 15, 2023
DOI 10.1155/2023/9652513
Devices mentioned K800552, K842399, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967 and 11 more
Product codes mentioned EPT, FPB, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature